Coloplast A Stock Z Score
| CLPBY Stock | USD 7.62 0.09 1.20% |
What is Altman Z-Score?
The Altman Z-Score is one of the most widely-used financial formulas to predict bankruptcy risk. Developed by Edward Altman in 1968, this model combines five key financial ratios to generate a single score that indicates the likelihood of financial distress within two years.
How to Interpret Coloplast Z-Score
Z-Score above 3.0: Safe zone - Low bankruptcy risk
Z-Score 2.7 - 3.0: Gray zone - Moderate risk
Z-Score 1.8 - 2.7: Warning zone - Elevated risk
Z-Score below 1.8: Distress zone - High bankruptcy risk
Why Coloplast Z-Score Matters
Investors use the Z-Score to assess financial health before making investment decisions. A declining Z-Score over time may signal deteriorating fundamentals, while an improving score suggests strengthening financial position. The model evaluates five critical metrics: working capital to assets, retained earnings to assets, EBIT to assets, market value of equity to total liabilities, and sales to assets.
Coloplast Z-Score Analysis
The module uses available fundamental data of Coloplast to calculate the Altman Z score based on five fundamental metrics from the company's most recent public disclosure documents. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Coloplast A. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Coloplast |
Coloplast 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Coloplast's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Coloplast.
| 11/23/2025 |
| 02/21/2026 |
If you would invest 0.00 in Coloplast on November 23, 2025 and sell it all today you would earn a total of 0.00 from holding Coloplast A or generate 0.0% return on investment in Coloplast over 90 days. Coloplast is related to or competes with Straumann Holding, Straumann Holding, Terumo, Terumo Corp, Sartorius Aktiengesellscha, Sartorius Stedim, and Orion Oyj. Coloplast AS engages in the development and sale of intimate healthcare products and services in Denmark, the United Sta... More
Coloplast Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Coloplast's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Coloplast A upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.18) | |||
| Maximum Drawdown | 9.98 | |||
| Value At Risk | (2.70) | |||
| Potential Upside | 1.73 |
Coloplast Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Coloplast's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Coloplast's standard deviation. In reality, there are many statistical measures that can use Coloplast historical prices to predict the future Coloplast's volatility.| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | (0.61) |
Coloplast February 21, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.1) | |||
| Market Risk Adjusted Performance | (0.60) | |||
| Mean Deviation | 1.12 | |||
| Coefficient Of Variation | (742.10) | |||
| Standard Deviation | 1.62 | |||
| Variance | 2.63 | |||
| Information Ratio | (0.18) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | (0.61) | |||
| Maximum Drawdown | 9.98 | |||
| Value At Risk | (2.70) | |||
| Potential Upside | 1.73 | |||
| Skewness | (1.34) | |||
| Kurtosis | 4.43 |
Coloplast A Backtested Returns
Coloplast A secures Sharpe Ratio (or Efficiency) of -0.12, which signifies that the company had a -0.12 % return per unit of risk over the last 3 months. Coloplast A exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Coloplast's Standard Deviation of 1.62, risk adjusted performance of (0.1), and Mean Deviation of 1.12 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.37, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Coloplast's returns are expected to increase less than the market. However, during the bear market, the loss of holding Coloplast is expected to be smaller as well. At this point, Coloplast A has a negative expected return of -0.2%. Please make sure to confirm Coloplast's value at risk, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Coloplast A performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.62 |
Good predictability
Coloplast A has good predictability. Overlapping area represents the amount of predictability between Coloplast time series from 23rd of November 2025 to 7th of January 2026 and 7th of January 2026 to 21st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Coloplast A price movement. The serial correlation of 0.62 indicates that roughly 62.0% of current Coloplast price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.62 | |
| Spearman Rank Test | 0.52 | |
| Residual Average | 0.0 | |
| Price Variance | 0.21 |
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
| Competition |
In accordance with the company's disclosures, Coloplast A has a Z Score of 0.6. This is 91.11% lower than that of the Healthcare sector and 88.79% lower than that of the Medical Instruments & Supplies industry. The z score for all United States stocks is 93.12% higher than that of the company.
Coloplast Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Coloplast's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Coloplast could also be used in its relative valuation, which is a method of valuing Coloplast by comparing valuation metrics of similar companies.Coloplast is currently under evaluation in z score category among its peers.
Coloplast Fundamentals
| Return On Equity | 0.75 | |||
| Return On Asset | 0.17 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.30 % | |||
| Current Valuation | 28.84 B | |||
| Shares Outstanding | 2.12 B | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Earning | 37.95 X | |||
| Price To Book | 22.46 X | |||
| Price To Sales | 1.13 X | |||
| Revenue | 22.58 B | |||
| Gross Profit | 15.53 B | |||
| EBITDA | 7.23 B | |||
| Net Income | 4.71 B | |||
| Cash And Equivalents | 854 M | |||
| Cash Per Share | 0.40 X | |||
| Total Debt | 16.36 B | |||
| Debt To Equity | 2.83 % | |||
| Current Ratio | 1.01 X | |||
| Book Value Per Share | 2.78 X | |||
| Cash Flow From Operations | 5.1 B | |||
| Earnings Per Share | 0.31 X | |||
| Price To Earnings To Growth | 3.39 X | |||
| Number Of Employees | 14.5 K | |||
| Beta | 0.21 | |||
| Market Capitalization | 24.94 B | |||
| Total Asset | 34.96 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 2.11 % | |||
| Net Asset | 34.96 B | |||
| Last Dividend Paid | 20.0 |
About Coloplast Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Coloplast A's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Coloplast using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Coloplast A based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Coloplast Pink Sheet Analysis
When running Coloplast's price analysis, check to measure Coloplast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast is operating at the current time. Most of Coloplast's value examination focuses on studying past and present price action to predict the probability of Coloplast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast's price. Additionally, you may evaluate how the addition of Coloplast to your portfolios can decrease your overall portfolio volatility.